EVEROLIMUS KRKA 10mg tablets
everolimus Indicated for: cancer; post-transplant immunosuppression
letter E · page 52
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
everolimus Indicated for: cancer; post-transplant immunosuppression
rivastigmine Indicated for: Alzheimer's disease; dementia
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
rivastigmine Indicated for: Alzheimer's disease; dementia
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
rivastigmine Indicated for: Alzheimer's disease; dementia
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
rivastigmine Indicated for: Alzheimer's disease; dementia
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases